Sarepta Therapeutics, Inc. Annual Costs and Expenses in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2014 to 2023.
  • Sarepta Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $364M, a 7.89% decline year-over-year.
  • Sarepta Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $1.47B, a 3.06% decline year-over-year.
  • Sarepta Therapeutics, Inc. annual Costs and Expenses for 2023 was $1.51B, a 2.86% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Costs and Expenses for 2022 was $1.47B, a 26.5% increase from 2021.
  • Sarepta Therapeutics, Inc. annual Costs and Expenses for 2021 was $1.16B, a 5.19% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.51B +$41.9M +2.86% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $1.47B +$308M +26.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.16B +$57.3M +5.19% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1.1B +$17.9M +1.65% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.09B +$442M +68.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $645M +$318M +97.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $326M +$54.1M +19.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $272M +$50.7M +22.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $221M +$77.9M +54.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $144M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.